Close

MabVax Therapeutics (MBVX) Offers Update on MVT-5873 Phase 1 in Pancreatic Cancer

Go back to MabVax Therapeutics (MBVX) Offers Update on MVT-5873 Phase 1 in Pancreatic Cancer